Rigel Pharma (RIGL) – Hot Corp. News
-
Lilly (LLY) and Rigel (RIGL) Enter Strategic Collaboration to Develop RIPK1 Inhibitors for the Potential Treatment of Immunological and Neurodegenerative Diseases
-
UPDATE: Rigel Pharma (RIGL) Reports Collaboration and License Agreement with Grifols S.A. (GRFS) to Commercialize Fostamatinib Disodium Hexahydrate in Europe and Turkey
-
-
-
-
-
-
-
-
-
-
-
Back to RIGL Stock Lookup